Your browser doesn't support javascript.
loading
Special Commentary: Food and Drug Administration and American Academy of Ophthalmology Sponsored: Developing Novel End Points for Premium Intraocular Lenses Workshop.
Lum, Flora; Tarver, Michelle E; Kahook, Malik Y; Oetting, Thomas A; Rorer, Eva; Hilmantel, Gene; Calogero, Don; Kiang, Tina; Berdahl, John P; Coleman, Anne L; Eydelman, Malvina B.
Afiliação
  • Lum F; H. Dunbar Hoskins, Jr., MD Center for Quality Eye Care, American Academy of Ophthalmology, San Francisco, California (on behalf of the American Academy of Ophthalmology).
  • Tarver ME; Office of Device Evaluation, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland.
  • Kahook MY; Department of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado (on behalf of the American Academy of Ophthalmology).
  • Oetting TA; Department of Ophthalmology, University of Iowa, Iowa City, Iowa (on behalf of the American Academy of Ophthalmology).
  • Rorer E; Office of Device Evaluation, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland.
  • Hilmantel G; Office of Device Evaluation, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland.
  • Calogero D; Office of Device Evaluation, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland.
  • Kiang T; Office of Device Evaluation, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland.
  • Berdahl JP; University of South Dakota School of Medicine, Sioux Falls, South Dakota (on behalf of the American Academy of Ophthalmology).
  • Coleman AL; Jules Stein Eye Institute, David Geffen School of Medicine and Fielding School of Public Health, University of California, Los Angeles, California (on behalf of the American Academy of Ophthalmology).
  • Eydelman MB; Office of Device Evaluation, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland. Electronic address: malvina.eydelman@fda.hhs.gov.
Ophthalmology ; 122(7): 1522-31, 2015 Jul.
Article em En | MEDLINE | ID: mdl-25896896
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oftalmologia / Sociedades Médicas / United States Food and Drug Administration / Determinação de Ponto Final / Lentes Intraoculares Tipo de estudo: Prognostic_studies / Sysrev_observational_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oftalmologia / Sociedades Médicas / United States Food and Drug Administration / Determinação de Ponto Final / Lentes Intraoculares Tipo de estudo: Prognostic_studies / Sysrev_observational_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2015 Tipo de documento: Article